H. Lundbeck A/S and Takeda Pharmaceutical Company Limited announced the initiation of a phase III clinical trial in Japan for Lu AA21004 in patients with ...

Read news

09-Mar-2011 | research and development

FDA accepts Lundbeck's submission of the New Drug Application for clobazam

H. Lundbeck A/S announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational ...

Read news

10-Feb-2011 | business & finance

Lundbeck expands its commercial opportunities in Canada and Latin America

H. Lundbeck A/S announced that Lundbeck has been granted commercial rights to several Cephalon products in Canada and Latin America. As part of the ...

Read news

Show more news about Lundbeck

Get the life science industry in your inbox

Lundbeck España S.A.

About Lundbeck

Product portfolio of Lundbeck

Product portfolio

News about Lundbeck

Genmab Reaches Second Milestone in Lundbeck Collaboration

Genmab announces progress with Lundbeck collaboration

Lundbeck and Proximagen Sign Strategic Partnership Agreement

Marie-Laure Pochon elected as Lundbeck's new EVP of Commercial Operations

Lundbeck: Nalmefene completes clinical phase III programme

H. Lundbeck starts clinical phase III study with Lu AA21004 in Japan

FDA accepts Lundbeck's submission of the New Drug Application for clobazam

Lundbeck expands its commercial opportunities in Canada and Latin America

Here you will find Lundbeck España S.A.

Lundbeck España S.A.